You are working on pharmaceutical development for protein or peptide based drugs…
You want to optimize your molecular screening processes and related costs…
You need fast, reliable, and transferable solutions for producing your active ingredients under GMP conditions (GMP peptide, GMP proteins, GMP API)…
- SYNPROSIS produces customized solutions on demand : long-chain synthetic peptides (> 200 AA) using solid-phase synthesis, purified and freeze-dried, in assorted quantities, using methods from the pharmaceutical and biological industries.
- SYNPROSIS complies with documentation procedures requested by both legislators and industry partners.
- SYNPROSIS is located in a 2,500 sqm facility GMP with ANSM certification for therapeutic peptide synthesis (GMP Certification Renewal in 2012) :
- 2006 : Certificate number 2006/HMP/FR0069
- 2012 : Certificate number HMP/FR/103/2012
- SYNPROSIS applies a “peptide drug fast track” protocol for developing your product from the API stage to the drug product: “First-in-Man” clinical batch
- Synprosis GMP Drug Product management
- SYNPROSIS works with you to develop pharmaceuticals, from preclinical and clinical development, with cGMP quality.